Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-03 Purchase |
2023-05-05 9:43 pm |
Prairie Operating Co. | CRKR | Breen Michael Martin Director |
916,112 | $0.109 | $99,856 | 1,257,183 (Direct) |
View |
| 2023-04-11 Purchase |
2023-04-11 6:59 pm |
GT Biopharma Inc. | GTBP | Breen Michael Martin Executive Chairman/Interim CEO |
50,000 | $0.5 | $25,000 | 656,218 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-08-11 Option Award |
2023-08-15 7:29 pm |
N/A N/A |
GT Biopharma Inc. | GTBP | Breen Michael Martin Executive Chairman/Interim CEO |
200,000 | $0.287 | 856,218 (Direct) |
View |
| 2018-10-16 Option Award |
2023-05-05 9:43 pm |
2018-10-16 2023-10-15 |
Prairie Operating Co. | CRKR | Breen Michael Martin Director |
67,500 | $0 | 1,257,183 (Direct) |
View |
| 2023-05-03 Option Award |
2023-05-05 9:43 pm |
N/A N/A |
Prairie Operating Co. | CRKR | Breen Michael Martin Director |
218,571 | $0.175 | 1,257,183 (Direct) |
View |
| 2023-01-27 Option Award |
2023-02-01 06:05 am |
N/A 2033-01-26 |
GT Biopharma Inc. | GTBP | Breen Michael Martin Exec Chairman and Interim CEO |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-07-15 Option Award |
2022-07-19 9:48 pm |
2022-07-15 2032-07-14 |
GT Biopharma Inc. | GTBP | Breen Michael Martin Exec. Chair. and Interim CEO |
328,058 | $0 | 656,218 (Direct) |
View |
| 2021-02-25 Conversion |
2021-11-12 12:01 pm |
2018-09-07 N/A |
GT Biopharma Inc. | GTBP | Breen Michael Martin Director |
130,000 | $0 | 378,160 (Direct) |
View |
| 2021-02-25 Conversion |
2021-11-12 12:01 pm |
N/A N/A |
GT Biopharma Inc. | GTBP | Breen Michael Martin Director |
50,102 | $3.4 | 378,160 (Direct) |
View |
| 2021-02-16 Option Award |
2021-11-12 12:01 pm |
N/A 2031-02-15 |
GT Biopharma Inc. | GTBP | Breen Michael Martin Director |
328,058 | $0 | 378,160 (Direct) |
View |
Ownership |
2021-11-12 12:01 pm |
2018-09-07 N/A |
GT Biopharma Inc. | GTBP | Breen Michael Martin Director |
0 | $0 | 0 (Direct) |
View |